p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence

Cited by (336)

Items 201–300 of 336

  1. Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity
    Kevin Jan Legscha, Edite Antunes Ferreira, Antonios Chamoun, Alexander Lang, Mohamed H.S. Awwad, Gigi Nu Hoang Quy Ton, Danuta Galetzka, Borhane Guezguez, Michael Hundemer, Jean‐Christophe Bourdon et al. · 2021 · Journal for ImmunoTherapy of Cancer
  2. p53 isoforms differentially impact on the POLι dependent DNA damage tolerance pathway
    Yitian Guo, Melanie Rall-Scharpf, Jean‐Christophe Bourdon, Lisa Wiesmüller, Stephanie Biber · 2021 · Cell Death and Disease
  3. Base excision repair accessory factors in senescence avoidance and resistance to treatments
    Elise Vickridge, Camila Cristina Fraga Faraco, Alain Nepveu · 2022 · Cancer Drug Resistance
  4. The Role of p53 Mutations in Early and Late Response to Mitotic Aberrations
    Anna Hertel, Zuzana Štorchová · 2025 · Biomolecules
  5. The pathological role of microRNAs and inflammation in colon carcinogenesis
    Lin Zhang, Xiaoming Fan · 2014 · Clinics and Research in Hepatology and Gastroenterology
  6. Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer
    Luiza Steffens Reinhardt, Kira Groen, Brianna C. Morten, Jean‐Christophe Bourdon, Kelly A. Avery‐Kiejda · 2022 · International Journal of Molecular Sciences
  7. Protein Interaction Between p53 and Δ113p53 Is Required for the Anti-Apoptotic Function of Δ113p53
    Zhao Ou, Le Yin, Changqing Chang, Jinrong Peng, Jun Chen · 2014 · Journal of genetics and genomics/Journal of Genetics and Genomics
  8. Immortalization of MEF is characterized by the deregulation of specific miRNAs with potential tumor suppressor activity
    Milena Rizzo, Monica Evangelista, Marcella Simili, Laura Mariani, Letizia Pitto, Giuseppe Rainaldi · 2011 · Aging
  9. Damage‐inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter
    James Blackburn, Daniel Lee Roden, Robert Ng, Jianmin Wu, Alexis Bosman, Richard J. Epstein · 2015 · Molecular Carcinogenesis
  10. The function of BCL11B in base excision repair contributes to its dual role as an oncogene and a haplo-insufficient tumor suppressor gene
    Elise Vickridge, Camila Cristina Fraga Faraco, Fanny Lo, Hedyeh Rahimian, Zi Yang Liu, Payman Samavarchi‐Tehrani, Billel Djerir, Zubaidah M. Ramdzan, Lam Leduy, Alexandre Maréchal et al. · 2023 · Nucleic Acids Research
  11. Expression of MDM2 in Macrophages Promotes the Early Postentry Steps of HIV-1 Infection through Inhibition of p53
    Yann Breton, Vincent Desrosiers, Michel Ouellet, Alexandre Deshière, Cynthia Torresilla, Éric A. Cohen, Michel J. Tremblay · 2019 · Journal of Virology
  12. The Inability of the Choroid to Revascularize in Oxygen-Induced Retinopathy Results from Increased p53/miR-Let-7b Activity
    Tianwei Ellen Zhou, Tang Zhu, José Carlos Rivera, Samy Omri, Houda Tahiri, Isabelle Lahaie, Raphaël Rouget, Maëlle Wirth, Stanley Nattel, Gregory Anton Lodygensky et al. · 2019 · American Journal Of Pathology
  13. How Driver Oncogenes Shape and Are Shaped by Alternative Splicing Mechanisms in Tumors
    Weronika Wojtyś, Magdalena Oroń · 2023 · Cancers
  14. Altered stoichiometry and nuclear delocalization of NonO and PSF promote cellular senescence
    Ching-Jung Huang, Utsab Das, Weijun Xie, Miryam Ducasse, Haley O. Tucker · 2016 · Aging
  15. Helpers of the cellular gatekeeper—miRNAs dance in P53 network
    Ming Shi, Dan Liu, Beifen Shen, Ning Guo · 2009 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  16. The DNA repair function of BCL11A suppresses senescence and promotes continued proliferation of triple-negative breast cancer cells
    Elise Vickridge, Camila Cristina Fraga Faraco, Payman Samavarchi‐Tehrani, Zubaidah M. Ramdzan, Billel Djerir, Hedyeh Rahimian, Lam Leduy, Alexandre Maréchal, Anne‐Claude Gingras, Alain Nepveu · 2022 · NAR Cancer
  17. Re-appraising the evidence for the source, regulation and function of p53-family isoforms
    Ignacio López, Irene Larghero Valdivia, Bořivoj Vojtěšek, Robin Fåhræus, Philip John Coates · 2024 · Nucleic Acids Research
  18. p53 protein expression in chronic lymphocytic leukemia
    Ludger Sellmann, Alexander Carpinteiro, Holger Nückel, René Scholtysik, Dörte Siemer, Ludger Klein-Hipass, Dieter Kube, Jan Dürig, Ulrich Dührsen, Jens Stanelle et al. · 2012 · Leukemia & lymphoma/Leukemia and lymphoma
  19. Interaction of p53 with the Δ133p53α and Δ160p53α isoforms regulates p53 conformation and transcriptional activity
    Fanny Tomas, Pierre Roux, Véronique Gire · 2024 · Cell Death and Disease
  20. Pushing the annotation of cellular activities to a higher resolution: Predicting functions at the isoform level
    Wenyuan Li, Chun-Chi Liu, Shuli Kang, Jianrong Li, Yu‐Ting Tseng, Xianghong Jasmine Zhou · 2015 · Methods
  21. New insights into the interactions of HPV-16 E6*I and E6*II with p53 isoforms and induction of apoptosis in cancer-derived cell lines
    Verónica Antonio-Véjar, Elizabeth Ortíz-Sánchez, Pedro Rosendo Chalma, Carlos César Patiño-Morales, Miriam Guido‐Jiménez, Eduardo Alvarado-Ortiz, Greco Hernández, Alejandro M. García-Carrancá · 2022 · Pathology - Research and Practice
  22. The Important Role of Protein Kinases in the p53 Sestrin Signaling Pathway
    Karsten Gülow, Deniz Tümen, C Kunst · 2023 · Cancers
  23. Absolute quantification of senescence mediators in cells using multiple reaction monitoring liquid chromatography-Tandem mass spectrometry
    Mariam Ahmed Galal, Mai Abdel Jabar, Mahmoud Zhra, Anas M. Abdel Rahman, Ahmad Aljada · 2021 · Analytica Chimica Acta
  24. Molecular and Cellular Biology
    Mary Ann Stevenson, Stuart K. Calderwood · 2015 · Elsevier eBooks
  25. Distinct functions of wild-type and R273H mutant Δ133p53α differentially regulate glioblastoma aggressiveness and therapy-induced senescence
    Sebastien M. Joruiz, Natalia von Muhlinen, Izumi Horikawa, Mark R. Gilbert, Curtis C. Harris · 2024 · Cell Death and Disease
  26. A defective splicing machinery promotes senescence through MDM4 alternative splicing
    Mathieu Deschênes, Mathieu Durand, Marc‐Alexandre Olivier, Alicia Pellerin‐Viger, Françis Rodier, Benoı̂t Chabot · 2024 · Aging Cell
  27. SLC30A4‐AS1 Mediates the Senescence of Periodontal Ligament Stem Cells in Inflammatory Environments via the Alternative Splicing of TP53BP1
    Xu Mei, Dian Gan, Xi‐Yu Zhang, Xiao‐Tao He, Rui Xin Wu, Yuan Yin, Rui Jin, Lin Li, Yu‐Jie Tan, Fa‐Ming Chen et al. · 2024 · Cell Proliferation
  28. Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets
    Zodwa Dlamini, Mohammed Alaouna, Sikhumbuzo Z. Mbatha, Ahmed Bhayat, Mzubanzi Mabongo, Aristotelis A. Chatziioannou, Rodney Hull · 2021 · Genes
  29. Involvement of astrocyte senescence in Alzheimer's disease
    Ferit Tüzer, Claudio A. Torres · 2022 · Current Opinion in Neurobiology
  30. Tracing the protectors path from the germ line to the genome
    Daniel Coutandin, Horng Der Ou, Frank Löhr, Volker Dötsch · 2010 · Proceedings of the National Academy of Sciences
  31. Germline variant affecting p53β isoforms predisposes to familial cancer
    Stephanie A Schubert, Dina Ruano, Sebastien M. Joruiz, Jordy Stroosma, Nikolina Glavak, Anna Montali, Lia Pinto, Mar Rodríguez‐Girondo, Daniela Q.C.M. Barge‐Schaapveld, Maartje Nielsen et al. · 2024 · Nature Communications
  32. Loss of digestive organ expansion factor (Diexf) reveals an essential role during murine embryonic development that is independent of p53
    Neeraj K. Aryal, Amanda R. Wasylishen, Vinod Pant, Maurisa Riley-Croce, Guillermina Lozano · 2017 · Oncotarget
  33. Molecular and Cellular Biology
    Mary Ann Stevenson, Stuart K. Calderwood · 2012 · Elsevier eBooks
  34. Combining TP53 mutation and isoform has the potential to improve clinical practice
    Sankalita Ray Das, Brett Delahunt, Annette Lasham, Kunyu Li, Deborah Wright, Cristin Gregor Print, Tania L. Slatter, Antony W. Braithwaite, Sunali Y. Mehta · 2024 · Pathology
  35. p53 Protein Isoform Profiles in AML: Correlation with Distinct Differentiation Stages and Response to Epigenetic Differentiation Therapy
    Ingvild Haaland, Sigrun M. Hjelle, Håkon Reikvam, André Sulen, Anita Ryningen, Emmet McCormack, Øystein Bruserud, Bjørn Tore Gjertsen · 2021 · Cells
  36. ΔNp73, TAp73 and Δ133p53 Extracellular Vesicle Cargo as Early Diagnosis Markers in Colorectal Cancer
    Javier Rodríguez‐Cobos, D. Viñal, Carmen F. Poves, María Jesús Fernández‐Aceñero, Héctor Peinado, Daniel Pastor‐Morate, Mª. Isabel Prieto, Rodrigo Barderas, Nuria Rodrı́guez-Salas, Gemma Domínguez · 2021 · Cancers
  37. Δ133p53 coordinates ECM-driven morphogenesis and gene expression in three-dimensional mammary epithelial acini
    Sun‐Young Lee, Claire Robertson, Alexandra Diot, Valerie Meuray, Jean‐Christophe Bourdon, Mina J. Bissell · 2022 · Journal of Cell Science
  38. Interaction between Autophagy and Senescence in Pancreatic Beta Cells
    Francesko Hela, Cristina Aguayo‐Mazzucato · 2023 · Biology
  39. The alternative translated MDMXp60isoform regulates MDM2 activity
    Anne-Sophie Tournillon, Ignacio López, Laurence Malbert-Colas, Nadia Naski, Vanesa Olivares‐Illana, Robin Fåhræus · 2015 · Cell Cycle
  40. Cell autonomous angiotensin II signaling controls the pleiotropic functions of oncogenic K-Ras
    Daniela Volonté, Morgan Sedorovitz, Victoria E. Cespedes, Maria L. Beecher, Ferruccio Galbiati · 2020 · Journal of Biological Chemistry
  41. The Role of p53‐Mediated Cellular Senescence in Idiopathic Pulmonary Fibrosis
    Yueyuan Jin, Mengna Jiang, Wenxia Bu, Yifan Zhou, Juan Tang, Shan Bao, Rui Zhao, Xinyuan Zhao, Demin Cheng · 2025 · Comprehensive physiology
  42. It is not all about the alpha: elevated expression of p53β variants is associated with lower probability of survival in a retrospective melanoma cohort
    Kira Groen, Luiza Steffens Reinhardt, Jean‐Christophe Bourdon, Kelly A. Avery‐Kiejda · 2023 · Cancer Cell International
  43. Δ133p53α-mediated inhibition of astrocyte senescence and neurotoxicity as a possible therapeutic approach for neurodegenerative diseases
    Izumi Horikawa, Leo Yamada, Brent T. Harris, Curtis C. Harris · 2025 · Neuroscience
  44. Characterization of SMG7 14-3-3-like domain reveals phosphoserine binding-independent regulation of p53 and UPF1
    Lauren E. Cowen, Hongwei Luo, Yi Tang · 2019 · Scientific Reports
  45. From Cancer to Rejuvenation: Incomplete Regeneration as the Missing Link (Part II: Rejuvenation circle)
    Mamuka G. Baramiya, Eugene Baranov, Irina N. Saburina, Lev Salnikov · 2020 · Future Science OA
  46. Alternative RNA splicing in cancer: what about adult T-cell leukemia?
    Julie Tram, Jean-Michel Mesnard, Jean‐Marie Péloponèse · 2022 · Frontiers in Immunology
  47. Participation of ATM, SMG1, and DDX5 in a DNA Damage-Induced Alternative Splicing Pathway
    Jennifer J. McCann, Donald E. Fleenor, Jing Chen, Chun-Hsiang Lai, Thomas E. Bass, Michael B. Kastan · 2023 · Radiation Research
  48. Identification and validation of a cellular senescence-related lncRNA signature for prognostic prediction in patients with multiple myeloma
    Tanlun Zeng, Sihan Jiang, Yichuan Wang, Guanqun Sun, Jinjin Cao, Dingtao Hu, Guang Wang, Xijun Liang, Jin Ding, Juan Du · 2023 · Cell Cycle
  49. EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells
    Akihiko Miyanaga, Masaru Matsumoto, Jessica A. Beck, Izumi Horikawa, Takahiro Oike, Hirokazu Okayama, Hiromi Tanaka, Sandra Sczerba Burkett, Ana I. Robles, Khan Ma et al. · 2021 · BMC Cancer
  50. Role of Cellular Senescence in Parkinson’s Disease: Potential for Disease-Modification Through Senotherapy
    David J. Rademacher, Jacob E. Exline, Eileen M. Foecking · 2025 · Biomedicines
  51. p53 and Its Isoforms in Renal Cell Carcinoma—Do They Matter?
    Agata Świątkowska · 2022 · Biomedicines
  52. Δ133p53/FLp53 Predicts Poor Clinical Outcome in Esophageal Squamous Cell Carcinoma
    Qimin Tu, Hongjian Gong, Chunhui Yuan, Gao Liu, Jinqi Huang, Zhichao Li, Jianfei Luo · 2020 · Cancer Management and Research
  53. Regulation of p53 by Helicobacter pylori
    Alexander I. Zaika, Jinxiong Wei, Jennifer M. Noto, Richard M. Peek · 2012 · Oncotarget
  54. Δ133p53α and Δ160p53α isoforms of the tumor suppressor protein p53 exert dominant-negative effect primarily by co-aggregation
    Liuqun Zhao, Tanel Punga, Suparna Sanyal · 2025 · eLife
  55. Alternative Splicing: Emerging Roles in Anti-Aging Strategies
    Lingyue Gao, Rong Jia · 2025 · Biomolecules
  56. A-674563 increases chondrocyte marker expression in cultured chondrocytes by inhibiting Sox9 degradation
    Tomohito Kobayashi, Kaori Fujita, Takashi Kamatani, Shuichi Matsuda, Noriyuki Tsumaki · 2017 · Biochemical and Biophysical Research Communications
  57. Time-Dependent Effects of POT1 Knockdown on Proliferation, Tumorigenicity, and HDACi Response of SK-OV3 Ovarian Cancer Cells
    Hua Zhou, Abdul Matin Mondal, Aleksandra Dakic, Lama Alhawas, Xuefeng Liu, Zhixu He · 2018 · BioMed Research International
  58. SATB1, senescence and senescence‐related diseases
    Wenjing Qi, Jinping Bai, Ruoxi Wang, Xianlu Zeng, Lihui Zhang · 2024 · Journal of Cellular Physiology
  59. Rad51c- and Trp53-double-mutant mouse model reveals common features of homologous recombination-deficient breast cancers
    Manuela Tumiati, Pauliina Munne, Henrik Edgren, Samuli Eldfors, Annabrita Hemmes, Sergey G. Kuznetsov · 2016 · Oncogene
  60. Crosstalk of moderate ROS and PARP‐1 contributes to sustainable proliferation of conditionally reprogrammed keratinocytes
    Linhua Liu, Abdul Matin Mondal, Xuefeng Liu · 2022 · Journal of Biochemical and Molecular Toxicology
  61. Prognostic role of TPL2 in early-stage non-small cell lung cancer
    Laura Boldrini, Mirella Giordano, Adele Servadio, Cristina Niccoli, Pietro Bertoglio, Marco Lucchi, Franca M. A. Melfi, Alfredo Mussi, Gabriella Fontanini · 2017 · Molecular Medicine Reports
  62. The Balance between p53 Isoforms Modulates the Efficiency of HIV-1 Infection in Macrophages
    Yann Breton, Corinne Barat, Michel J. Tremblay · 2021 · Journal of Virology
  63. p53 isoforms have a high aggregation propensity, interact with chaperones and lack binding to p53 interaction partners
    Anamari Brdar, Christian Osterburg, Philipp Münick, Anne Christin Machel, Rajeshwari Rathore, Susanne Osterburg, Büşra Yüksel, Birgit Schäfer, Kristina Desch, Julian D. Langer et al. · 2024 · eLife
  64. SRSF3 knockdown-induced cellular senescence as a possible therapeutic strategy for non-small cell lung cancer
    Shinji Nakamichi, Natalia von Muhlinen, Leo Yamada, Jilian R. Melamed, Tyler Ellis Papp, Hamideh Parhiz, Drew Weissman, Izumi Horikawa, Curtis C. Harris · 2025 · Carcinogenesis
  65. Working title: Molecular involvement of p53‐MDM2 interactome in gastrointestinal cancers
    Yedla Poornachandra, Pranav Bhamidipati, Riyaz Syed, Ramars Amanchy · 2024 · Cell Biochemistry and Function
  66. A Quantitative High-Throughput Screen Identifies Compounds that Upregulate the p53 Isoform Δ133p53α and Inhibit Cellular Senescence
    Delphine Lissa, Sebastien M. Joruiz, Patricia K. Dranchak, Kyra Ungerleider, Leo Yamada, Izumi Horikawa, Erin N. Oliphant, Rebecca Manubag, Natalia von Muhlinen, Jessica A. Beck et al. · 2025 · ACS Pharmacology & Translational Science
  67. Oxidative Telomere Attrition, Nutritional Antioxidants and Biological Aging
    Michael J. Glade · 2015 · International Journal Of Nutrition
  68. SRp20: A potential therapeutic target for human tumors
    Han Wang, Yanxia Jiang · 2021 · Pathology - Research and Practice
  69. Δ113p53/Δ133p53: survival and integrity
    Jun Chen, Jinrong Peng · 2015 · Oncotarget
  70. Exploring p53 isoforms: unraveling heterogeneous p53 tumor suppressor functionality in uveal melanoma
    Laura Bartolomei, Yari Ciribilli, Samuele Brugnara, Francesco Reggiani, Gian Mario Moretta, Mariangela Petito, Elisa Marcaccini, Marianna Ambrosio, Carlo Mosci, Ulrich Pfeffer et al. · 2025 · Cell Death Discovery
  71. From molecular damage to regulatory constraint: epigenetic and metabolic limits of cellular plasticity in aging
    Antoni Godlewski, Tomasz Dziaman · 2026 · Frontiers in Aging
  72. Progressive hippocampal senescence and persistent memory deficits in traumatic brain Injury: A role of delayed testosterone
    Jacob E. Exline, Michael Volyanyuk, Krista M. Lotesto, Arthur B. Segismundo, Susanna C. Byram, Eileen M. Foecking · 2025 · Brain Research
  73. Translation of human Δ133p53 mRNA and its targeting by antisense oligonucleotides complementary to the 5′-terminal region of this mRNA
    Paulina Żydowicz-Machtel, Mariola Dutkiewicz, Agata Świątkowska, Dorota Gurda, Jerzy Ciesiołka · 2021 · PLoS ONE
  74. A Novel Role of SMG1 in Cholesterol Homeostasis That Depends Partially on p53 Alternative Splicing
    Muyang Li, Fredrick Philantrope, Alexandra Diot, Jean‐Christophe Bourdon, Patricia A. Thompson · 2022 · Cancers
  75. New Δ246p53 isoform responds to DNA damage to enhance p53 family functions in cellular senescence
    Shrutee N. Parkar, Ana Catarina Ramalho, Maria José López-Iniesta, Silva Ricardo, Jingyuan Zhao, Koto Kimura, Vanessa Dassi, Filipa da Silva Rita, Yari Ciribilli, Alessandra Bisio et al. · 2026 · Cell Death Discovery
  76. Δ133p53α and Δ160p53α isoforms of the tumor suppressor protein p53 exert dominant-negative effect primarily by co-aggregation
    Liuqun Zhao, Tanel Punga, Suparna Sanyal · 2025 · eLife
  77. The senescence-inhibitory p53 isoform Δ133p53α: enhancing cancer immunotherapy and exploring novel therapeutic approaches for senescence-associated diseases
    Shinji Nakamichi, Leo Yamada, Christopher Roselle, Izumi Horikawa, Carl H. June, Curtis C. Harris · 2025 · GeroScience
  78. p53 Isoforms as Modifiers of the p53-Dependent Responses: A Hidden Code?
    Laura Bartolomei, Beatrice Pretto, Samuele Brugnara, Alessandra Sontacchi, Vanessa Dassi, Aya Bousrih, Chiara Damaggio, Francesca Flangini, Alessandra Bisio, Yari Ciribilli · 2026 · Cancers
  79. The Role of Nonsense-mediated mRNA Decay in Aging
    Eunseok Kang, Hyunwoo C. Kwon, Seung‐Jae Lee · 2026 · Journal of Molecular Biology
  80. Molecular mechanisms and recent advances in cellular senescence
    Ashaq Hussain, Marc Tatar, Rujun Gong · 2026 · Cell & Bioscience
  81. T cell senescence and exhaustion: molecular mechanisms and immune rejuvenation for cancer immunotherapy
    Lauren van den Broecke, Arne Van der Vreken, Fenja Watté, Fien Meeus, Kim De Veirman, Karine Breckpot, Elke De Bruyne, Eline Menu · 2026 · Signal Transduction and Targeted Therapy
  82. Pro-senescence Therapy for Cancer: Time for the Clinic
    Madhuri Kalathur, Diletta Di Mitri, Andrea Alimonti · 2014 · Springer eBooks
  83. The more the merrier
    Sophie R. Atkinson · 2009 · Nature reviews. Cancer
  84. Investigating Cancer-related Proteins Specific Domain Interactions and Differential Protein Interactions Caused by Alternative Splicing
    Yu-Liang Lee, Jie-Wei Weng, Wen-Chin Chiang, Yi-Wen Lin, Ka‐Lok Ng, Jeffrey Tsai, Chi‐Ying F. Huang · 2011 · IEEE International Conference on Bioinformatics and Bioengineering (BIBE)
  85. p53 and Vascular Dysfunction: MicroRNA in Endothelial Cells
    Munekazu Yamakuchi, Sushil Panta, Teruto Hashiguchi · 2018 · InTech eBooks
  86. Cutaneous immunohistochemical staining pattern of p53β isoforms
    Christine J. Ko, Peggy S. Myung, David J. Leffell, Jean‐Christophe Bourdon · 2018 · Journal of Clinical Pathology
  87. BRCA-1 mediated activation of NF-κβ and its pro-inflammatory network drives tumorigenesis in benign breast disease patients
    Jeyakumar Balakrishnan, Ambujam Govindasamy, Suganya Kannan, R. Arunagiri · 2022 · Human Gene
  88. A novel DNA damage-induced alternative splicing pathway that regulates p53 and cellular senescence markers
    Jing Chen, Michael B. Kastan · 2017 · Oncoscience
  89. Balancing senescence and apoptosis: therapeutic insights into aging and cancer
    Nusrat Jan, Shazia Sofi, Aijaz Ahmad Mir, Gowhar Masoodi, Manzoor Ahmad Mir · 2025 · Molecular and Cellular Biochemistry
  90. The molecular mechanisms and therapeutic potential of p53 in kidney injury repair: a perspective on the p53alpha/delta133p53alpha signaling axis
    Jiayan Fan, Yitian Guo, Guanhua Cui, Qiu Li, Nieke Zhang, Shuchun Tao, Hang Wu, Guangyuan Zhang · 2025 · Renal Failure
  91. TP53 Splice Mutations Have Tumour-Independent Effects on Genomic Stability and Prognosis: An In Silico Study
    Apeksha Arun Bhandarkar, Noah Ethan Kelly-Foleni, Debina Sarkar, Aaron R. Jeffs, Tania L. Slatter, Antony W. Braithwaite, Sunali Y. Mehta · 2025 · International Journal of Molecular Sciences
  92. Regulation of oncogenic C-terminal truncated p53β protein isoform expression by SRSF3–UPF1 splicing and surveillance axis
    Jiwon Jeong, Dawon Hong, Tae Young Park, Jung Hur, Taeyoung Koo, S Jeong-Yu · 2026 · Cell & Bioscience
  93. Biology of p53 protein isoforms and their significance in hematological malignancies
    Anna Maria Janik, Zuzanna Tracz‐Gaszewska, Irena Misiewicz-Krzemińska, Krzysztof Jamroziak · 2026 · Frontiers in Oncology
  94. p53: Point Mutations, SNPs and Cancer
    Ming Fang, Iva Simeonova, Franck Toledo · 2012 · InTech eBooks
  95. Signaling Networks Controlling Cellular Senescence
    Leena P. Desai, Yan Y. Sanders, Victor John Thannickal · 2014 · Wiley eBooks
  96. Regulation of Senescence by microRNAs
    Ioannis Grammatikakis, Myriam Gorospe · 2013 · Wiley eBooks
  97. RAD51C IS A TUMOR SUPPRESSOR IN MAMMARY AND SEBACEOUS GLANDS
    Manuela Tumiati · 2015 · Työväentutkimus Vuosikirja
  98. Inflammation, senescence and cancer: interweaving microRNA, inflammatory cytokines and p53 networks
    Curtis C. Harris · 2010 · BMC Proceedings
  99. Telomerase and cellular aging: analysis of telomerase RNA structure and the impact of telomerase on miRNA expression
    Laura N. Bonifacio · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  100. Determining the role of scavenger receptor class B type I as a source of cholesterol for de novo androgen synthesis in castration-resistant prostate cancer
    Ankur Midha · 2015 · cIRcle (University of British Columbia)